Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) typically begins to affect appetite within the first one to two weeks of the starting 2.5mg dose, though meaningful weight change usually takes four to eight weeks to register on the scales. Most people notice reduced hunger before they notice any change in body weight. Like every prescription-only medicine, it requires a clinical assessment before a prescriber can determine whether it's suitable for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is a question our prescribers hear most weeks. The short answer is: for many people, yes, but not quite on day one. Tirzepatide activates two gut-hormone receptors, GIP and GLP-1, which work together to slow gastric emptying and increase the sense of fullness after eating. That mechanism can begin influencing hunger signals within the first few days. By the end of the first week, a large proportion of people on the 2.5mg starter dose report that meals feel satisfying sooner, or that the urge to snack has quietly reduced.
What the starter dose is not designed to do is produce rapid weight loss. Its job is to let your body acclimatise to the medicine before the prescriber considers moving you up. You can read more about how tirzepatide's dual mechanism works on our tirzepatide overview page. The appetite effect is real from early on; the metabolic effect builds gradually over months, not days.
One practical note: if you are curious about how soon Mounjaro works, some people feel little change in the first week and worry the medicine is not working, but that early period is normal. Changes in hunger are subtle and easy to miss if you are not paying attention to portion sizes and fullness cues, keeping a brief food log in the first fortnight can help you spot a shift that felt invisible at the time.
The trial data give a useful anchor here. In the SURMOUNT-1 study, published in the New England Journal of Medicine, thousands of adults took tirzepatide over 72 weeks alongside a reduced-calorie diet and increased activity. Average body-weight reduction reached around 20–21% at the highest dose. That figure accumulated across the full trial period, it did not arrive in the first month.
In practice, most people see a measurable drop on the scales somewhere between four and eight weeks in, typically corresponding to the transition from the starter pen toward the 5mg dose. The loss is gradual and tends to accelerate as the dose titrates upward. Expecting a dramatic change in the first two weeks usually leads to frustration; expecting steady progress over six to twelve months is closer to what the evidence supports.
Body composition changes can also precede scale changes. Reduced bloating, a looser waistband, or better sleep may appear before the number on the scales shifts noticeably. Our page on when Mounjaro starts working covers the broader picture of what typical timelines look like for different people. Thinking about cost alongside the timeline is also reasonable, our guide to Mounjaro pricing in the UK sets out what to expect without the misleading headlines.
Honestly, sometimes yes. Nausea, loose stools, constipation, indigestion, and fatigue are the most commonly reported early experiences, and they tend to peak in the days immediately after the first or second injection. The NHS's patient guidance on tirzepatide notes that these gastrointestinal effects are usually mild to moderate and tend to improve within one to two weeks as the body settles.
That front-loading of side effects before obvious benefits is one reason some people stop early. The evidence suggests that persistence through the adjustment period is where the results lie. Eating smaller, lower-fat meals, staying well hydrated, and not injecting on an empty stomach all help most people manage the early phase. Timing your injection on a consistent day each week also reduces the unpredictability.
A word on what warrants attention: severe, persistent abdominal pain that radiates toward the back is different from ordinary nausea. That symptom (especially alongside vomiting) should prompt prompt medical review, in line with the MHRA's safety communications on GLP-1 medicines. Report any unexpected or serious side effects via the Yellow Card scheme.
Several factors shape the individual timeline. Starting weight matters: someone starting at a higher BMI may see larger absolute losses early, though percentage change tends to converge over time. Dietary habits during treatment influence the pace, tirzepatide reduces appetite but does not override calorie balance entirely. Activity level, sleep quality, and medication interactions can all shift the trajectory.
Dose titration is probably the biggest variable. People who stay on 2.5mg for longer than the standard four-week period (perhaps due to tolerability, or supply, or prescriber preference) will see slower early progress than those who move through the schedule as planned. If you want a detailed breakdown of how soon after taking Mounjaro it starts to work, that can help you set realistic expectations alongside your prescriber's guidance. That is why the weight-loss treatment options available through a regulated service always sit inside a clinical relationship, not a one-off transaction.
If you are weighing up whether Mounjaro is the right option for your situation, or wondering how soon Mounjaro starts to work given your individual circumstances, the clearest next step is a conversation with a prescriber who can look at the full picture. Our clinical team reviews every consultation personally. Check your eligibility and start your free consultation, there is no obligation, and the review happens the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.